NEWTOPIA INC - NEWUF STOCK NEWS

Newtopia Inc. (TSXV: NEWU; OTCQB: NEWUF) announced a successful presentation at the AHIP 2022 conference on June 22, 2022, focusing on how behavioral genetics can enhance health engagement and reduce costs. The event highlighted high interest in Newtopia's health platform, which aims to prevent chronic diseases and improve health outcomes. Additionally, the company completed a non-brokered private placement, raising $110,000 by selling 550,000 units at $0.20 each. Each unit includes a common share and a warrant priced at $0.30, exercisable until May 11, 2024.

Newtopia Inc. (TSXV: NEWU, OTCQB: NEWUF) reported Q1 2022 revenue of $2.9 million, a 9.5% increase from Q1 2021. Participant engagements reached an all-time high of 38,000, up 27% year-over-year. The gross profit margin decreased to 47% from 50% due to increased sales of lower-margin Welcome Kits. The company successfully closed a $3.5 million private placement, enhancing its balance sheet. Looking ahead, Newtopia anticipates full year revenue growth, particularly in the second half of 2022, supported by expanding customer phases and a new platform launch.

Newtopia Inc. (TSXV: NEWU, OTCQB: NEWUF) will release its financial results for Q1 2022 on May 18, 2022, after market close. A conference call is scheduled for the same day at 5:00 PM ET to discuss the results. Interested participants can join by dialing the provided numbers or via a live webcast on Newtopia's investor relations website. The company focuses on disease prevention through tech-enabled habit change, aiming to improve health outcomes and reduce care costs for insurers.

Newtopia Inc. announced the appointment of Collin Swenson as the new Chief Financial Officer, effective immediately, succeeding Edmond Lem. Swenson brings over 15 years of experience in financial leadership, previously holding key roles at companies like General Electric and Valeo. CEO Jeff Ruby expressed gratitude for Lem's contributions and excitement about Swenson’s expertise, highlighting it as beneficial for the company's growth and shareholder value enhancement. Newtopia focuses on chronic disease prevention through innovative health solutions.

Newtopia Inc. (NEWUF), a provider of tech-enabled habit change focused on chronic disease prevention, announced that its Founder and CEO, Jeff Ruby, will participate in the Bloom Burton & Co. Healthcare Investor Conference on May 2nd and 3rd, 2022. Jeff Ruby is scheduled to present on May 3rd at 3:00 PM ET, with a live webcast available on Newtopia's investor relations website. The company offers personalized health programs to combat diseases such as type 2 diabetes and heart disease, serving large employers and health plans.

Newtopia Inc. reported its Q4 and full-year 2021 results, with Q4 revenue at $2.4 million, a slight decline from $2.5 million in Q4 2020. Full-year revenue was $10.5 million, down from $11.4 million. Despite these declines, gross profit margins improved, reaching 52% in Q4 and 49% for the year. The company achieved a record of 135,500 participant engagements, a 14% increase year-over-year. Looking ahead, Newtopia anticipates year-over-year revenue growth in 2022, bolstered by new partnerships and a strong participant base.

Newtopia Inc. (TSXV: NEWU, OTCQB: NEWUF) expands its partnership with a leading apparel company to enhance employee mental health. The initiative utilizes Newtopia's habit change platform, addressing anxiety and depression, following success in reducing physical risks associated with metabolic diseases. Notable achievements include a 39% weight loss in participating employees and an 80% engagement rate over 12 months. Starting June 2022, the program focuses on cognitive behavioral therapy and personalized health coaching, aiming to improve mental resilience while promoting overall well-being.

Newtopia, a tech-enabled habit change provider, announced it will release its financial results for the quarter ended December 31, 2021, post-market on April 5, 2022. A conference call will take place at 5:00 p.m. Eastern Time to discuss these results in detail. Newtopia focuses on disease prevention, particularly for chronic conditions like type-2 diabetes and heart disease, using personalized programs based on genetic, social, and behavioral insights. The company is listed on the TSXV (NEWU) and OTCQB (NEWUF).

Newtopia announced the engagement of Stonegate Capital Partners to enhance its visibility among U.S. investors. The collaboration aims to communicate Newtopia's growth story, primarily driven by its revenue from U.S.-based health insurers. Stonegate will assist in expanding investor relations, starting from a fee of US$5,000 per month. This partnership comes after Newtopia's quotation on the OTCQB Venture Market in August 2021, reflecting the company's strategy to broaden its investor communication.